Efficacy, safety, and cost-effectiveness of meningococcal vaccines.
10.3760/cma.j.issn.0254-6450.2019.02.002
- Collective Name:Chinese Preventive Medicine Association
- Publication Type:Review
- Keywords:
Cost-effectiveness;
Efficacy;
Immunogenicity;
Meningococcal vaccine;
Persistence;
Safety
- MeSH:
Cost-Benefit Analysis;
Humans;
Immunization/economics*;
Meningitis, Meningococcal/prevention & control*;
Meningococcal Vaccines/immunology*;
Vaccination/economics*;
Vaccines, Conjugate/immunology*
- From:Chinese Journal of Epidemiology
2019;40(2):129-135
- CountryChina
- Language:Chinese
-
Abstract:
Meningococcal meningitis is an acute, severe respiratory infectious disease caused by Neisseria meningitidis. Immunization with meningococcal vaccine is the most effective measure to control and prevent transmission of meningococcal meningitis. Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine containing meningococcal polysaccharide conjugate vaccine. This article reviews research progress on the efficacy, safety, and cost-effectiveness of meningococcal vaccines, particularly in the Chinese market, to support appropriate use of the various meningococcal vaccines for preventing meningococcal meningitis.
